Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer

PURPOSE: Randomized evidence for extreme hypofractionation in prostate cancer is lacking. We aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and extreme hypofractionated radiation in a phase 3 randomized trial. METHODS AND MATERIALS: We analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Carlos E., Schmidt, Matthew Q., Niska, Joshua R., Hartsell, William F., Keole, Sameer R., Doh, Lucius, Chang, John Han-Chih, Sinesi, Christopher, Rodriquez, Rossio, Pankuch, Mark, Larson, Gary L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128091/
https://www.ncbi.nlm.nih.gov/pubmed/30202801
http://dx.doi.org/10.1016/j.adro.2018.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128091/
https://www.ncbi.nlm.nih.gov/pubmed/30202801
http://dx.doi.org/10.1016/j.adro.2018.02.004

Ejemplares similares